Risultati della ricerca - Yoshiko Kichikawa
- Mostra 1 - 2 risultati su 2
-
1
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) di T. Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, Katsuya Shiraki, Yuji Hirai, Yoshiko Kichikawa, Kenji Tsushima, Masaharu Shinkai, Naoyuki Komura, Kazuo Yoshida, Yasutoshi Kido, Hiroshi Kakeya, Naoto Uemura, Jun‐ichi Kadota
Pubblicazione 2022Artigo -
2
Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer di Shunsuke Kondo, Satoshi Iwata, Taketo Yamada, Yusuke Inoue, Hiromi Ichihara, Yoshiko Kichikawa, Tomoki Katayose, Akiko Souta-Kuribara, Hiroto Yamazaki, Osamu Hosono, Hiroshi Kawasaki, Hirotoshi Tanaka, Yuichiro Hayashi, Michiie Sakamoto, Kazunori Kamiya, Nam H. Dang, Chikao Morimoto
Pubblicazione 2012Artigo
Strumenti per la ricerca:
Soggetti correlati
Alternative medicine
Asymptomatic
Biology
Cancer
Cancer research
Cell
Cell biology
Cell culture
Clinical trial
Double blind
Gastroenterology
Gene knockdown
Genetics
Integrin
Internal medicine
Kidney disease
Medicine
Metastasis
Pathology
Placebo
Placebo-controlled study
Proto-oncogene tyrosine-protein kinase Src
Randomization
Randomized controlled trial
Signal transduction
Tyrosine phosphorylation